INTRODUCTION
Upper respiratory tract disease (URTD) in tortoises is primarily caused by Mycoplasma agassizi; the pathogenicity of this agent has been confirmed experimentally in two American tortoise species (Brown et al., 1994 (Brown et al., , 1999b . Mycoplasma-infected tortoises have cyclic URTD signs, and recrudescence may occur in response to anthropogenic influences (United States Fish and Service, 1994; Brown et al., 1999a) . This disease has caused significant morbidity and mortality in free-living Mojave Desert tortoises (Gopherus agassizi) (Brown et al., 1994; Jacobson, 1994) and Southeastern US gopher tortoises (Gopherus polyphemus) (Brown et al., 2001) . Cases of URTD in captive tortoises also are caused by M. agassizi, as confirmed by polymerase chain reaction (PCR), culture, and serology (Jacobson et al., 1991; Brown et al., 2001) .
A URTD-like syndrome (URTD-LS) closely resembling URTD in tortoises was recently identified in free-ranging eastern box turtles (Terrapene carolina carolina) from several counties in Virginia, USA. Coincident with URTD-LS was another distinct syndrome characterized by aural abscesses; these animals sometimes also had signs associated with URTD in tortoises and turtles (ocular and nasal discharge and eyelid swelling). Virginia box turtles affected with aural abscesses typically have histologic lesions consistent with vitamin A deficiency; a link between aural abscesses and organochlorine compounds has been hypothesized (Holladay et al., 2001) .
Major objectives of this study involving box turtles with URTD-LS and detectable mycoplasma were to identify the type and prevalence of clinical signs in Mycoplasma sp.-positive animals, screen for other potential causes of URTD (herpesvirus, iridovirus), characterize the phylogenetic relationship of this box turtle Mycoplasma sp. to other pathogenic Mycoplasma spp., and present the partial geographic distribution of this agent in Virginia.
MATERIALS AND METHODS

Turtles
The index case was a wild-caught male eastern box turtle identified in May 2001, from Greene County Virginia, USA, within 1 mile of the eastern boundary of Shenandoah National Park (38u2092499N, 78u2992699W). The affected individual had serous to mucopurulent nasal discharge, swollen ocular adnexal tissues, epiphora, and a loss of body condition. The index case transmitted URTD-LS to a cohoused previously unaffected female box turtle known to be free of clinical signs for over a year prior to infection. Both cases initially responded to tylosin, and the female was maintained in captivity and subsequently cleared of clinical URTD-LS by application of extended clarithromycin treatment (Wimsatt et al., 1999) . A Mycoplasma sp. was detected in nasal swabs from this female using a consensus Mycoplasma sp. 16S rRNA PCR (validated to detect verified M. agassizi in captive desert tortoises by the Colorado State University State Diagnostic Laboratory; Wimsatt, unpubl. data, 2001 ) followed by development and testing with a box turtle Mycoplasma sp. sequence-specific PCR. The sequence-specific PCR detected the box turtle mycoplasma and M. agassizi but not other distantly related Mycoplasma spp. The DNA of this new box turtle mycoplasma was used as a positive control for screening subsequently collected turtle samples.
Subsequently, samples obtained from native box turtles submitted to the Wildlife Center of Virginia from May 2002 to August 2003 or animals identified with URTD-LS, aural abscesses, or other unrelated diseases during routine herpetological surveys were assayed by box turtle Mycoplasma sp. sequence-specific PCR. Samples were obtained using saline premoistened swabs (RayonH culturette, Fisher Scientific, Houston, USA) of oculonasal secretions from animals with URTD-LS signs. Alternatively, swabs collected from saline nasal flushes of animals without overt URTD-LS signs were submitted for PCR. Samples were placed into saline-containing sealed tubes, refrigerated or quick frozen at 220 C, and transported to the Center for Comparative Medicine, University of Virginia, Charlottesville, Virginia, for testing.
DNA extraction
The DNA was isolated from culturettes using DNeasy silica spin columns (Qiagen, Valencia, California, USA) as follows. The tip of each culturette was placed into a sterile 1.5-ml microfuge tube containing 180 ml of buffer ATL and 20 ml of proteinase-K solution. The swab and digestion reagents were vortexed 10 sec followed by incubation at 55 C for 2 hr with shaking. Subsequently, each swab was discarded, and 200 ml of absolute ethanol and 200 ml of buffer AL (Qiagen) were added to the eluted sample. The solution was vortexed 10 sec, applied to a spin column, centrifuged (60 sec at 11,400 3 G), and washed according to the manufacturer's instructions. Immobilized DNA was eluted from the column by application of 50 ml of 70 C distilled water, incubation for 60 sec, and centrifugation (60 sec, 11,400 3 G). A 5-ml aliquot of each eluted sample was subjected to DNA amplification using a validated PCR assay optimized to detect the box turtle Mycoplasma sp. Primer specificity was determined based on comparisons of GenBank accessions with sequences obtained from clinical material. In addition, amplicon size and verification of base sequences were further validations.
PCR amplification of mycoplasma 16S rRNA gene and amplicon cloning
The PCR primer sequences (59 to 39) used for amplification were as follows: sense (Escherichia coli position 449) CTGCTGTTA-TACAGAAAGAAAAG and antisense (E. coli position 1466) GACTTTGGGCATTACC-GGC. Each 50-ml PCR reaction contained 0.5 mM of each primer, 200 mM of each deoxynucleotide triphosphate, 1.5 mM MgCl 2 , 2.5 units of Taq polymerase (HotstarH, Qiagen), and 1X buffer supplied with the enzyme. Amplification was performed using a Robocycler 9600 gradient thermal cycler (Stratagene, La Jolla, California, USA). Thermal cycler settings were one cycle of 14 min and 15 sec at 95 C (hotstart); 35 cycles of denaturation at 95 C for 45 sec, annealing at 55 C for 1 min, extension at 72 C for 1 min 15 sec; and one cycle of final extension at 72 C for 5 min. The amplified products (993 nucleotides) from four positive samples (three symptomatic, one asymptomatic turtles) representing different Virginia geographical regions were cloned into plasmid pCR4 TOPO (Invitrogen Corporation, Carlsbad, California, USA) and transformed into competent E. coli Top 10H (Invitrogen). Two bacterial clone replicates produced from each sample were selected and further grown in Luria Bertani (LB) broth; plasmids were biotyped and purified using the Plasmid Mini Kit (Invitrogen). The biotyped plasmids were subjected to DNA sequencing by Davis Sequencing (davissequencing.com, University of California at Davis, Davis, California, USA). Overall, two replicate clones were analyzed to determine the consensus sequence of a given amplification product, and four distinct amplification products from turtles with differing clinical presentations and geographic locations were analyzed to determine the partial 16S rRNA consensus sequence for the Mycoplasma sp. DNA from Virginia box turtles.
Phylogenetic analyses of partial mycoplasma 16S rRNA gene sequence A partial sequence comparison was made of 16S rRNA accessions from several Mycoplasma spp. in the National Institutes of Health GenBank. The DNA sequences were aligned using the PILEUP software in the WisconsinH software package (Accelrys, Inc., Cambridge, UK), and the resulting alignment made compatible with the PHYLIP analysis software (PHYLIP: Phylogeny Inference Package, version 3.6a2, 1993, J. Felsenstein, Department of Genetics, University of Washington, Seattle, Washington, USA) using the READSEQ routine. The GenBank sequences were all truncated to correspond with the 59-and 3-9 ends of the DNA sequence determined for the box turtle Mycoplasma sp. One thousand data sets were generated from the alignment using SEQBOOT and bootstrap analysis of the data sets, jumbling the input sequence order three times. DNAPARS software was used to find the most parsimonious trees. The consensus at branch points of the 1,000 trees was determined using CONSENSE, and the resulting phylogram was displayed using TREE-VIEW (R. D. M. Page, 2001, Division of Environmental and Evolutionary Biology, Institute of Biomedical and Life Sciences, University of Glasgow, Glasgow G12 8QQ, Scotland, UK). The consensus phylogram furnishes the number of candidate phylograms out of the 1,000 generated, agreeing at any particular junction. An agreement of 500 of more phylograms at a branch point was considered significant (i.e., indicating a statistically significant relationship among sequences analyzed around that branch point).
Bacterial isolation
Culture for Mycoplasma spp. was attempted and consisted of sample filtration (0.8 mm pore size) and plating on SP-4 (Remel Inc., Lexana, Kansas, USA) agar. Culture conditions consisted of incubation under anaerobic conditions at 30 C as previously described (Brown et al., 2001 ).
Screening for other causes of URTD
The same samples were also screened by PCR for chelonian herpesviruses (Van Devanter et al., 1996; Une et al., 2000) and invertebrate (Just et al., 2001 ) and vertebrate (including FV3) (Mao et al., 1997; Marschang et al., 1999) iridoviruses.
RESULTS
Of 23 animals screened for Mycoplasma sp., seven animals representing six counties were PCR positive (Table 1; Fig. 1 ). The 16 turtles PCR negative for mycoplasma were dispersed over the seven counties examined, and some counties contained both PCR positive and negative turtles. Six counties had animals with aural abscessation (Table 1) , but these were not necessarily identical to those counties with turtles PCR positive for Mycoplasma sp. (Green County had one PCR positive turtle without aural abscessation; Louisa County had one turtle with aural abscessation without detectable mycoplasma).
Six of the seven Mycoplasma sp.-positive turtles had clinical signs of URTD-LS (Table 1) . Clinical signs were similar to those observed in tortoises infected with M. agassizi and included serous to mucopurulent nasal and ocular discharge, and erythematous swollen conjunctivas. Three animals had typical URTD-LS signs without aural abscessation, and two of these had no detectable Mycoplasma sp. from PCR ( (Fig. 2 ). In contrast, the two M. agassizii sequences have 99.8% sequence identity (differing at only two nucleotides within the 993 bp of sequence analyzed). The phylogram (Fig. 3 ) depicts the close relationship of the Virginia box turtle Mycoplasma sp. sequence to the two Mycoplasma agassizii sequences deposited in GenBank but implies that a unique Mycoplasma sp. sequence was identified within this chelonian clade (i.e., the branch point of the box turtle Mycoplasma sp. sequence represented a consensus among all 1,000 phylograms). The close phylogenetic relationship of M. agassizii to M. hyorhinis (Brown et al., 1995) is preserved in the box turtle Mycoplasma sequence (Fig. 3) . Mycoplasma pulmonis, a respiratory and genitourinary pathogen of rodents, resides within this clade as well.
DISCUSSION
Mycoplasma agassizi is the preponderant causative agent responsible for URTD in desert and gopher tortoises (Brown et al., 1994 (Brown et al., , 1999b ; endemic M. agassizi disease has resulted in population declines of wild native tortoises (Jacobson et al., 1991; Brown et al., 1994; United States Fish and Wildlife Service, 1994; Brown et al., 1999b; Holladay et al., 2001) , and the same agent affects a wide range of other tortoise species with a cyclical pattern of URTD signs (Brown et al., 1999a (Brown et al., , b, 2001 Brown, 2002) . Mycoplasma agassizii was recently identified from a wild-caught Florida Gulf Coast, USA, box turtle (T. c. bauri) with URTD (Brown et al., 2001 after Siefkas et al., 1998) and was hypothesized, but not confirmed, to be the cause of an over-winter die-off of radio-tracked eastern box turtles from North Carolina, USA (Rossell et al., 2002) .
Occult mycoplasma infection is punctuated with cyclical appearance of clinical signs during M. agassizi infection in tortoises (Brown et al., 1999a) ; this pattern of disease expression in the tortoises is consistent with observations involving the characterization of mycoplasma associated URTD-LS of eastern box turtles in this series. Our results are consistent with the observation regarding PCR detection of mycoplasma in tortoises, in that animals serving as carriers may only intermittently shed (Brown et al., 1999b) . Thus, in the absence of confirmatory tests, long-term monitoring of suspect turtles for the appearance of clinical signs may be warranted prior to translocation, to avoid spreading the disease.
Positive PCR detection indicates direct agent identification, a potential advantage over serological diagnosis. In our limited series, PCR detection was greater in animals with overt clinical signs (notably oculonasal discharge), similar to M. agassizi detection in captive desert tortoises; however, presence of clinical signs per se did not have a 100% correspondence with PCR detection in a captive colony of United States Fish and Wildlife Servicedonated Mycoplasma-positive tortoises diagnosed by enzyme-linked immunoabsorbent assay (ELISA) (Wimsatt, unpubl. data) . Although a single nasal flush from an asymptomatic turtle tested PCR positive, routine screening for mycoplasma would be expected to have a low yield because of the preponderance of animals without disease and those not shedding the organism.
Serological screening for antimycoplasma antibodies has been widely used to detect mycoplasma carriers in wild tortoise species (Brown et al., 1999a) . The seroprevalence of eastern box turtles from Pennsylvania, USA (Belzer, 1996) , and New York State, USA (Calle et al., 1998) , for M. agassizi were 0% and 43%, respectively, using ELISA with reagents validated in tortoises for detection of M. agassizi. These surveys suggested no association of seropositive animals with clinical signs, suggesting either false positive serology results or the presence of an avirulent mycoplasma in New York turtles. A more recent survey detected seropositive resident, rehabilitated and repatriated box turtles in a state park in southeastern New York, and a single culture-positive asymptomatic resident wild animal was identified at this study site (P. Calle, pers. comm., 2003) . Even so, caution is warranted in interpreting a tortoise-validated serology test in other species (United States Fish and Wildlife Service, 1994; Lee et al., 2003) .
Eastern box turtles may range widely, increasing the likelihood of disease transmission and dissemination. In addition, they engage in considerable conspecific contact during courtship and during aggressive displays between males (Dodd, 2001) ; stress associated with courtship and the opportunity for close contact could increase the likelihood of mycoplasma transmission between turtles. Desert tortoises frequently share burrows (especially summer burrows and Mojave tortoise aggregates [Lederle et al., 1997] ) in small groups (Ernst and Barbour, 1989) , and this behavior may contribute to Mycoplasma agassizi spread. In contrast, eastern box turtles often burrow singly (Dodd, 2001) ; even so, whether this behavioral difference is sufficient to reduce the risk of mycoplasma transmission in box turtles is unknown. The potential impact of environmental cofactors on the occurrence and recrudescence of URTD signs has been highlighted for desert tortoises harboring M. agassizi (Lederle et al., 1997) .
In a recent survey, significant morbidity in Virginia box turtles that often had signs indistinguishable from URTD-LS was attributed to anthropogenic trauma and aural abscessation (Brown and Sleeman, 2002) . Aural abcessation was an occasional finding in one survey of free-living Virginia box turtles brought to a rehabilitation center (Brown and Sleeman, 2002) . In the present series, some Virginia box turtles with aural abscessation presented similar to those seen in URTD-LS. The present study does not provide support for a relationship between aural abscess development and mycoplasma infection. The relationship between mycoplasma colonization, URTD-LS in box turtles, and the contribution of other etiologic factors such as those associated with aural abscessation warrant further study. Recently it has been proposed that organochlorine-induced vitamin A deficiency may predispose box turtles to aural abscess formation, common in native Virginia box turtles (Holladay et al., 2001 ) and may explain how vitamin A deficiency could occur in wild turtles on natural diets. Other factors may predispose to aural abscessation (Murray, 1996) . For example, aural abscessation has been reported from wild box turtles from New York (P. Calle, pers. comm., 2003) , North Carolina (K. Grayson, pers. comm., 2006) , and Florida (Dodd and Griffey, 2004) , where it was attributed to high rainfall.
Turtles with mycoplasma were fortuitously collected by the public and by biologists performing herpetological surveys. Thus, case distribution may be more a reflection of proximity to the Wildlife Center of Virginia and where surveys were performed rather than a reflection of the true distribution of disease. Mycoplasma cases detected via the Wildlife Center were fortuitously selected from a considerably larger group submitted to the center, and sampling was likely biased in favor of animals with clinical signs of either aural abscessation, URTD-LS, or the timing of available turtles to sample.
Although molecular analysis of the Virginia box turtle Mycoplasma sp. was performed to determine its taxonomic relationship to known Mycoplasma spp., further characterization based on the organism's biochemical properties, serum cross-neutralization assays, and culture requirements is required. However, repeated attempts to isolate this fastidious organism using SP-4 agar as previously described (Brown et al., 2001 ) have been unsuccessful, currently making further characterization impossible. Although there is some evidence of disease transmission from this report, isolation of this new putative Mycoplasma sp. is needed for controlled challenge studies to fulfill Koch's postulates and to confirm that it is a primary pathogen, as was previously demonstrated for M. agassizi in native tortoise species (Brown et al., 1994 (Brown et al., , 1999b .
The impact of M. agassizi-induced disease on native Mojave Desert and Southeastern US gopher tortoise populations has been dramatic and well documented (Homer et al., 1998; Brown et al., 1999a) . Similarly, M. agassizi is endemic in Sonoran Desert tortoise populations south of the Colorado River, yet the population does not appear to be declining from URTD (Dickinson et al., 2002) , and the distribution of differing genetic assemblages based on mitchondial DNA typing does appear to directly map to mycoplasma disease expression (Lamb and McLuckie, 2002) . Current evidence supports greater food and water availability and life style differences as cofactors in the decline of desert tortoises in the Mojave life zone (Lamb and McLuckie, 2002) . Thus, a careful evaluation of the role of Mycoplasma sp. strain (virulence) differences and the impact of concurrent environmental stressors on the expression of disease in Eastern box turtles are factors worthy of further investigation.
If the Mycoplasma sp. of eastern box turtles proves to have either a primary or secondary pathogenic effect (opportunistically capitalizing upon anthropogenic or environmental disturbances), better estimates of its impact on over-winter mortality and population dynamics are of utmost importance to safeguard native turtle populations for future generations. In addition, the occurrence of this Mycoplasma in other turtle species of the US mid-Atlantic region and detailed mapping of the distribution of this Mycoplasma sp. are critical to assess its ultimate impact.
